Stay updated on Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Location entry for Italy changed from Padua, Italy, 35128 to Padova, Italy, 35128. The page revision was updated to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T21:36:18.000Z thumbnail image
  2. Check
    16 days ago
    No Change Detected
  3. Check
    24 days ago
    Change Detected
    Summary
    Added Naples, Italy, 80131 as a trial site. Removed Napoli, Italy, 80131 and Melanoma and MedlinePlus Genetics-related topics from the related topics section.
    Difference
    0.1%
    Check dated 2026-03-26T04:13:01.000Z thumbnail image
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T22:56:04.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Melanoma and related topics, including MedlinePlus Genetics, were added; the page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T20:11:57.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Melanoma content and the MedlinePlus Genetics related topics were removed from the page.
    Difference
    0.1%
    Check dated 2026-03-04T15:07:30.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    Added Melanoma topic, MedlinePlus Genetics link, and a new JAMA Netw Open citation related to adjuvant pembrolizumab in melanoma.
    Difference
    0.1%
    Check dated 2026-02-25T10:29:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Stage II Melanoma Clinical Trial page.